Yang XH - Search Results

1

["Re-evaluation upon suspected event" is an approach for post-marketing clinical study: lessons from adverse drug events related to Bupleuri Radix preparations].

Wu SX, Sun HF, Yang XH, Long HZ, Ye ZG, Ji SL, Zhang L. Wu SX, et al. Among authors: yang xh. Zhongguo Zhong Yao Za Zhi. 2014 Aug;39(15):2983-8. Zhongguo Zhong Yao Za Zhi. 2014. PMID: 25423845 Chinese.

2

[Current status and development of monitoring on adverse reaction of traditional Chinese medicine in China].

Zhang L, Yang XH, Cao LY, Ji S. Zhang L, et al. Among authors: yang xh. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Jul;25(7):581-4. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005. PMID: 16089130 Chinese.

3

[Retrospective study of adverse events of Polygonum multiflorum and risk control].

Zhang L, Yang X, Sun Z, Qu Y. Zhang L, et al. Zhongguo Zhong Yao Za Zhi. 2009 Jul;34(13):1724-9. Zhongguo Zhong Yao Za Zhi. 2009. PMID: 19873791 Chinese.

4

[Pharmacovigilance idea should be introduced sufficiently into the safety monitoring and evaluation process of Chinese drugs].

Zhang L, Yang XH. Zhang L, et al. Among authors: yang xh. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Sep;29(9):843-6. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009. PMID: 19960988 Chinese.

5

[Evaluation and consideration on safety information abroad of Polygonum multiflorum and its preparations].

Zhang L, Yang X, Deng Y. Zhang L, et al. Zhongguo Zhong Yao Za Zhi. 2009 Sep;34(18):2414-8. Zhongguo Zhong Yao Za Zhi. 2009. PMID: 20030101 Chinese.

6

[Retrospective study on Xiaohe tablet-related liver damage and discussion on risk control].

Zhang L, Yang X, Guo P, Tong Y. Zhang L, et al. Zhongguo Zhong Yao Za Zhi. 2010 Aug;35(16):2199-203. Zhongguo Zhong Yao Za Zhi. 2010. PMID: 21046762 Chinese.

7

Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.

Zhang L, Yan J, Liu X, Ye Z, Yang X, Meyboom R, Chan K, Shaw D, Duez P. Zhang L, et al. J Ethnopharmacol. 2012 Apr 10;140(3):519-25. doi: 10.1016/j.jep.2012.01.058. Epub 2012 Feb 21. J Ethnopharmacol. 2012. PMID: 22374080 Free article. Review.

8

[Post-marketing clinical study of traditional Chinese medicine--lessons learned from comprehensive evaluation of Fufang Zaoren capsule].

Qing S, Gao L, Zhang L, Jia JP, Liu XM, Ji SL, Yang XH. Qing S, et al. Among authors: yang xh. Zhongguo Zhong Yao Za Zhi. 2013 Nov;38(21):3790-4. Zhongguo Zhong Yao Za Zhi. 2013. PMID: 24494575 Chinese.

9

[Safety evaluation and risk control measures of Psoralea corylifolia].

Tian WY, Lan S, Zhang L, Sun L, Huang JK, Yang XH, Sun GB, Gao XM, Sun XB. Tian WY, et al. Among authors: yang xh. Zhongguo Zhong Yao Za Zhi. 2017 Nov;42(21):4059-4066. doi: 10.19540/j.cnki.cjcmm.20170919.011. Zhongguo Zhong Yao Za Zhi. 2017. PMID: 29271140 Chinese.

10

[Systematic evaluation for safety of traditional Chinese medicine Areca catechu and its preparations].

Sun L, Song HB, Zhang L, Huang JK, Wang JX, Yang XH, Sun GB, Gao XM, Sun XB. Sun L, et al. Among authors: yang xh. Zhongguo Zhong Yao Za Zhi. 2017 Nov;42(21):4067-4073. doi: 10.19540/j.cnki.cjcmm.20170919.014. Zhongguo Zhong Yao Za Zhi. 2017. PMID: 29271141 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,028 results

Search Page